Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Environmental sustainability assessment of the manufacturing process of a biological active pharmaceutical ingredient
Ana Gabriela Renteria Gamiz, Wouter De Soete, Bert Heirman, et al.
Journal of Chemical Technology & Biotechnology (2019) Vol. 94, Iss. 6, pp. 1937-1944
Closed Access | Times Cited: 25

Showing 25 citing articles:

Dynamic life cycle assessment (LCA) integrating life cycle inventory (LCI) and Enterprise resource planning (ERP) in an industry 4.0 environment
Anna María Ferrari, Lucrezia Volpi, Davide Settembre-Blundo, et al.
Journal of Cleaner Production (2020) Vol. 286, pp. 125314-125314
Closed Access | Times Cited: 137
Can biotechnology lead the way toward a sustainable pharmaceutical industry?
Deniz Etit, Samir Meramo, Ólafur Ögmundarson, et al.
Current Opinion in Biotechnology (2024) Vol. 87, pp. 103100-103100
Open Access | Times Cited: 10
Application of Life Cycle Assessment in the Pharmaceutical Industry: A Critical Review
Zhengyun Chen, Justin Z. Lian, Hengyi Zhu, et al.
Journal of Cleaner Production (2024) Vol. 459, pp. 142550-142550
Open Access | Times Cited: 10
A holistic framework for integrated sustainability assessment of pharmaceuticals
Lisa Van Wilder, Lieselot Boone, Ad M.J. Ragas, et al.
Journal of Cleaner Production (2024) Vol. 467, pp. 142978-142978
Closed Access | Times Cited: 8
Climate footprint of industry-sponsored clinical research: an analysis of a phase-1 randomised clinical study and discussion of opportunities to reduce its impact
Jason LaRoche, Rodrigo A.F. Alvarenga, Michael Collins, et al.
BMJ Open (2024) Vol. 14, Iss. 1, pp. e077129-e077129
Open Access | Times Cited: 7
Green metrics in pharmaceutical development
Concepción Jiménez‐González, Claire Lund
Current Opinion in Green and Sustainable Chemistry (2021) Vol. 33, pp. 100564-100564
Closed Access | Times Cited: 31
Effect of alternative dosing strategies of pembrolizumab and nivolumab on health-care emissions in the Netherlands: a carbon footprint analysis
Ruben Malmberg, Jurrien H Loosveld, Hans-Peter Schilte, et al.
The Lancet Planetary Health (2024) Vol. 8, Iss. 11, pp. e915-e923
Closed Access | Times Cited: 4
Life cycle assessment as a tool for the environmental improvement of the leather industry
Velusamy Mozhiarasi, Sara Zahedi Nezhad, Velmurugan Punitha, et al.
Elsevier eBooks (2025), pp. 305-336
Closed Access
Climate footprint of industry-sponsored in-human clinical trials: life cycle assessments of clinical trials spanning multiple phases and disease areas
Jason LaRoche, Jason Lanier, Rodrigo A.F. Alvarenga, et al.
BMJ Open (2025) Vol. 15, Iss. 2, pp. e085364-e085364
Open Access
Cost–Benefit Analysis of Monoclonal Antibody Cultivation Scenarios in Terms of Life Cycle Environmental Impact and Operating Cost
Eri Amasawa, Hiroaki Kuroda, Kozue Okamura, et al.
ACS Sustainable Chemistry & Engineering (2021) Vol. 9, Iss. 42, pp. 14012-14021
Open Access | Times Cited: 27
A PSE perspective for the efficient production of monoclonal antibodies: integration of process, cell, and product design aspects
Sara Badr, Hirokazu Sugiyama
Current Opinion in Chemical Engineering (2020) Vol. 27, pp. 121-128
Open Access | Times Cited: 27
Comparison of process mass intensity (PMI) of continuous and batch manufacturing processes for biologics
Sri Ranganayaki Madabhushi, Nuno D. S. Pinto, Henry Lin
New Biotechnology (2022) Vol. 72, pp. 122-127
Closed Access | Times Cited: 16
Environmental life cycle assessment of nutraceuticals: A case study on methylcobalamin in different packaging types
Margot Cooreman-Algoed, Lieselot Boone, Evelien Uitterhaegen, et al.
The Science of The Total Environment (2023) Vol. 893, pp. 164780-164780
Closed Access | Times Cited: 8
Advantages and drawbacks of life cycle assessment application to the pharmaceuticals: a short critical literature review
Marco Satta, Fabrizio Passarini, Daniele Cespi, et al.
Environmental Science and Pollution Research (2024)
Open Access | Times Cited: 3
Technical Potential for Energy and GWP Reduction in Chemical–Pharmaceutical Industry in Germany and EU—Focused on Biologics and Botanicals Manufacturing
A. Schmidt, Lukas Uhlenbrock, Jochen Strube
Processes (2020) Vol. 8, Iss. 7, pp. 818-818
Open Access | Times Cited: 21
Selecting optimal pharmaceutical excipient formulation from life cycle assessment perspectives: A case study on ibuprofen tablet formulations
Danping Wang, Wean Sin Cheow, Nur Dina Amalina, et al.
Journal of Cleaner Production (2021) Vol. 292, pp. 126074-126074
Closed Access | Times Cited: 19
Life cycle assessment of pharmaceuticals: the ciprofloxacin hydrochloride case
Kexuan Yang, Bihong Lv, Huazhen Shen, et al.
The International Journal of Life Cycle Assessment (2020) Vol. 26, Iss. 1, pp. 64-75
Closed Access | Times Cited: 18
Comparing the environmental impacts of paracetamol dosage forms using life cycle assessment
Rachit Kumar Sharma, Geo Raju, Prabir Sarkar, et al.
Environment Development and Sustainability (2021) Vol. 24, Iss. 10, pp. 12446-12466
Closed Access | Times Cited: 13
The long journey of a benzodiazepine
Harjas Kaur, Fiona Parascandalo, Emma Ko, et al.
EarthArXiv (California Digital Library) (2024)
Open Access | Times Cited: 1
Eco-pharma dilemma: Navigating environmental sustainability trade-offs within the lifecycle of pharmaceuticals – A comment
Caroline Moermond, Neele Puhlmann, Lowik Pieters, et al.
Sustainable Chemistry and Pharmacy (2024) Vol. 43, pp. 101893-101893
Open Access | Times Cited: 1
Design and optimization of spherical agglomeration process based on machine learning strategy
Chenyang Zhao, Yanbo Liu, Shilin Guo, et al.
AIChE Journal (2024) Vol. 70, Iss. 10
Closed Access | Times Cited: 1
Cradle-to-gate life cycle assessment of a liquid pharmaceutical product through analysis of chemical production pathways
Çağrı Emre Güneş, Hatice Şengül
Clean Technologies and Environmental Policy (2022) Vol. 24, Iss. 6, pp. 1741-1755
Closed Access | Times Cited: 5
Environmental impacts associated with the manufacturing of personalised medicines: a scoping review
Mustafa Hussein Ajlan Al-Jarshawi, Anneke Lucassen, Gabrielle Samuel
(2023)
Open Access | Times Cited: 2
Green metrics for biologics
Sarah Argoud, Kristi L. Budzinski, Daniel D’Aquila, et al.
Current Opinion in Green and Sustainable Chemistry (2022) Vol. 35, pp. 100614-100614
Closed Access | Times Cited: 4
Environmental sustainability assessment as a driver for selection of the manufacturing processes of a bispecific T-cell engager
Monica Gabriela, Benjamin T. Smith, Bart Connors, et al.
Reaction Chemistry & Engineering (2024) Vol. 9, Iss. 10, pp. 2773-2783
Closed Access
Page 1

Scroll to top